Infant botulism
Infant botulism is a paralytic syndrome which manifests as a result of ingesting spores of the toxin secreting bacterium Clostridium botulinum by infants. As opposed to botulism in adults, treating infant botulism with horse antiserum was not approved due to several safety issues. This restriction has led to the development of Human Botulism Immune Globulin Intravenous (BIG-IV; sells under BabyBIG). In this article we review infant botulism and the advantages of treating it with BIG-IV.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:153 |
|---|---|
| Enthalten in: |
Harefuah - 153(2014), 3-4 vom: 09. März, Seite 180-3, 238 |
| Sprache: |
Hebräisch |
|---|
| Beteiligte Personen: |
Falk, Absalom [VerfasserIn] |
|---|
| Themen: |
Botulism immune globulin |
|---|
| Anmerkungen: |
Date Completed 15.05.2014 Date Revised 05.05.2014 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM237906929 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM237906929 | ||
| 003 | DE-627 | ||
| 005 | 20231224112642.0 | ||
| 007 | tu | ||
| 008 | 231224s2014 xx ||||| 00| ||heb c | ||
| 028 | 5 | 2 | |a pubmed24n0793.xml |
| 035 | |a (DE-627)NLM237906929 | ||
| 035 | |a (NLM)24791561 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a heb | ||
| 100 | 1 | |a Falk, Absalom |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infant botulism |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 15.05.2014 | ||
| 500 | |a Date Revised 05.05.2014 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Infant botulism is a paralytic syndrome which manifests as a result of ingesting spores of the toxin secreting bacterium Clostridium botulinum by infants. As opposed to botulism in adults, treating infant botulism with horse antiserum was not approved due to several safety issues. This restriction has led to the development of Human Botulism Immune Globulin Intravenous (BIG-IV; sells under BabyBIG). In this article we review infant botulism and the advantages of treating it with BIG-IV | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Immunoglobulins |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a botulism immune globulin |2 NLM | |
| 700 | 1 | |a Afriat, Amichay |e verfasserin |4 aut | |
| 700 | 1 | |a Hubary, Yechiel |e verfasserin |4 aut | |
| 700 | 1 | |a Herzog, Lior |e verfasserin |4 aut | |
| 700 | 1 | |a Eisenkraft, Arik |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Harefuah |d 1946 |g 153(2014), 3-4 vom: 09. März, Seite 180-3, 238 |w (DE-627)NLM000070491 |x 0017-7768 |7 nnns |
| 773 | 1 | 8 | |g volume:153 |g year:2014 |g number:3-4 |g day:09 |g month:03 |g pages:180-3, 238 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 153 |j 2014 |e 3-4 |b 09 |c 03 |h 180-3, 238 | ||